 |
 |
Cytopathology
Welcome to the Cytopathology Section of the Division of Anatomical Pathology. Diagnostic
cytopathology involves the interpretation of cells that are spontaneously exfoliated or are
removed from tissue by abrasion or fine needle aspiration biopsy (FNAB).
The cytopathology service at The Ottawa Hospital offers a comprehensive cytodiagnostic,
screening and consultative service, including examination of approximately 14,000 gynecological
(Pap smear) specimens, 6,500 non-gynecological specimens, and 3,200 fine needle aspiration
biopsies, annually. The service is staffed by cytopathologists, cytotechnologists, and
cytotechnicians.
The cytopathology service has an outstanding quality assurance program
that consists of correlating all current cytology specimens with surgical
pathology specimens. Our goal is to achieve accurate and cost-effective
cytologic diagnosis in a timely manner. The section also provides training
for pathology residents and cytotechnology students.
Fine Needle Aspiration Biopsy (FNAB)
Fine needle aspiration biopsy (FNAB) is a simple, quick, non-invasive, cost- effective, and most
importantly, accurate method for diagnosis of cancer. However, it is also used to diagnose benign
tumours and inflammatory / infectious disease. Using the morphology and ancillary techniques
such as immunocytochemistry helps to make a definitive diagnosis in a non-invasive way,
therefore, decreasing the number of invasive and more costly diagnostic interventions. One
example of the value of FNAB is the screening and diagnosis of patients with thyroid nodules.
Thyroid nodules are common and FNAB of the thyroid saves many patients from unnecessary
surgery.
It is a simple procedure, requiring minutes to perform, while providing a diagnosis or significant
clinical information in over 90% of cases. Clinicians aspirate almost any superficial palpable
lesions, such as lumps in the breast, lymph nodes, soft tissue, etc. Under radiologic guidance,
radiologists aspirate deep-seated lesions from lung, liver, pancreas, etc, with adequacy
assessment by cytotechnologists.
PAP Smear
 |
| Three
cells show changes
of HPV infection |
For half a century the Pap test has contributed to a marked decline in the morbidity and mortality
of cervical cancer. This test is still one of the very few tests available which has the ability to
prevent cancer rather than simply detect it. We use a "state-of-the-art" liquid-based cytology
screening test. The advantage of liquid-based cytology testing is that one can perform Hybrid
Capture assay for HPV from the same specimen, if the latter is deemed necessary. The ability to
do cytology and HPV testing on a single specimen results in decreased patient visits and
procedures, minimizes patient anxiety, and saves time and resources. We use the new Bethesda
System for reporting of these specimens.
Non-Gynecologic Cytopathology
Non-gynecologic cytology is performed primarily for the diagnosis of cancer. Non-gynecologic
samples that lend themselves to cytology evaluation include: effusions (pleural, abdominal,
pericardial), cerebral spinal fluid, sputum, urine, and washings/brushings (bronchus, esophagus,
stomach, etc.).
|  |
|
 |